Get started
ARROWHEAD PHARMACEUTICALS INC COM USD0.001ARROWHEAD PHARMACEUTICALS INC COM USD0.001ARROWHEAD PHARMACEUTICALS INC COM USD0.001

ARROWHEAD PHARMACEUTICALS INC COM USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

0HI3 chart

Key stats

Market capitalization
‪2.93 B‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.77USD
Net income
‪−205.28 M‬USD
Revenue
‪240.74 M‬USD
Shares float
‪117.63 M‬
Beta (1Y)
1.88

About ARROWHEAD PHARMACEUTICALS INC COM USD0.001

Sector
Health Technology
Industry
Biotechnology
CEO
Christopher Richard Anzalone
Website
arrowheadpharma.com
Headquarters
Pasadena
Employees (FY)
525
Founded
1989
ISIN
US04280A1007
FIGI
BBG00JVRN7B1
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0HI3 is 23.22 USD — it has decreased by 3.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stocks are traded under the ticker 0HI3.
ARROWHEAD PHARMACEUTICALS INC COM USD0.001 is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ARROWHEAD PHARMACEUTICALS INC COM USD0.001 has a max estimate of 90.00 USD and a min estimate of 28.00 USD.
0HI3 earnings for the last quarter are −1.02 USD whereas the estimation was −0.61 USD which accounts for −67.60% surprise. Estimated earnings for the next quarter are −0.80 USD. See more details about ARROWHEAD PHARMACEUTICALS INC COM USD0.001 earnings.
ARROWHEAD PHARMACEUTICALS INC COM USD0.001 revenue for the last quarter amounts to ‪16.09 M‬ USD despite the estimated figure of ‪44.63 M‬ USD. In the next quarter revenue is expected to reach ‪33.87 M‬ USD.
Yes, you can track ARROWHEAD PHARMACEUTICALS INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
Like other stocks, 0HI3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
0HI3 reached its all-time high on Feb 10, 2021 with the price of 92.15 USD, and its all-time low was 5.16 USD and was reached on Feb 14, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 525.00 employees. See our rating of the largest employees — is ARROWHEAD PHARMACEUTICALS INC COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARROWHEAD PHARMACEUTICALS INC COM USD0.001 EBITDA is ‪−285.35 M‬ USD, and current EBITDA margin is −79.97%. See more stats in ARROWHEAD PHARMACEUTICALS INC COM USD0.001 financial statements.